EUVIMEDEUVIMED entdecken
Crossref

Preoperative Tranexamic Acid Use in Free Flap Breast Reconstruction: A Propensity‐Matched Analysis of Postoperative Outcomes

Ramin Shekouhi, Brandon Byrd, Christopher Branstetter, Harvey Chim iD

Microsurgery · 2026-03 · 46 (3)

DOI: 10.1002/micr.70201 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microsurgery, online erschienen am 26.02.2026. Verfasst von Ramin Shekouhi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Plastic and Reconstructive Surgery, Department of Surgery, Louisiana StateUniversity Health Sciences Center, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Tranexamic Acid, Mammaplasty, Free Tissue Flaps, Antifibrinolytic Agents. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Tranexamic acid ( TXA ), an antifibrinolytic agent, has demonstrated efficacy in reducing perioperative bleeding across multiple surgical interventions. While increasingly utilized in breast reconstruction, evidence regarding its role in free flap procedures remains limited and inconsistent. This study evaluates the impact of preoperative TXA administration on postoperative outcomes in free flap breast reconstruction.

Methods

A retrospective cohort study was performed using the TriNetX research network to identify patients undergoing free flap breast reconstruction. Patients receiving preoperative TXA were compared with those who did not. Propensity score matching was applied to balance demographic and clinical variables. Primary outcomes included hematoma, seroma, bleeding, venous thrombosis, and flap loss.

Results

Among 20,778 patients, 524 (2.5%) received preoperative TXA . After 1:1 propensity score matching, 524 TXA patients were compared with 524 controls. Hematoma rates were significantly higher in the TXA group (21.2% vs. 15.3%, RR 0.72, 95% CI 0.55–0.94, p = 0.01). Seroma occurred more frequently in TXA patients (23.2% vs. 18.9%) but was not statistically significant ( p > 0.05). Postoperative bleeding, venous thrombosis, and flap loss rates were comparable. Intraoperative hemorrhage occurred exclusively in the non‐ TXA group (≤ 1.9% vs. 0%, p = 0.001).

Conclusions

Contrary to prior reports, preoperative TXA use in free flap breast reconstruction was associated with a higher incidence of hematoma, without significant reduction in the rate of other complications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidMammaplastyFree Tissue FlapsAntifibrinolytic AgentsPostoperative ComplicationsPostoperative HemorrhageBlood Loss, SurgicalHumansFemaleRetrospective StudiesMiddle AgedPropensity ScoreAdultTreatment OutcomePreoperative Care

Stichwörter der Autor:innen

autologous breast reconstructionbreast reconstructiondatabasefree flaptranexamic acid

Substanzen

Tranexamic AcidAntifibrinolytic Agents

Autor:innen und Institutionen

  • Division of Plastic and Reconstructive Surgery, Department of Surgery, Louisiana StateUniversity Health Sciences Center, New Orleans, Louisiana, USA.
  • College of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana, USA.

ORCID-Profile: Harvey Chim

Zitieren

APA

Shekouhi, R., Byrd, B., Branstetter, C., & Chim, H. (2026). Preoperative Tranexamic Acid Use in Free Flap Breast Reconstruction: A Propensity‐Matched Analysis of Postoperative Outcomes. Microsurgery, 46(3). https://doi.org/10.1002/micr.70201

Vancouver

Shekouhi R, Byrd B, Branstetter C, Chim H. Preoperative Tranexamic Acid Use in Free Flap Breast Reconstruction: A Propensity‐Matched Analysis of Postoperative Outcomes. Microsurgery. 2026;46(3). doi:10.1002/micr.70201

BibTeX
@article{Shekouhi2026,
  author = {Shekouhi, Ramin and Byrd, Brandon and Branstetter, Christopher and Chim, Harvey},
  title = {Preoperative Tranexamic Acid Use in Free Flap Breast Reconstruction: A Propensity‐Matched Analysis of Postoperative Outcomes},
  journal = {Microsurgery},
  year = {2026},
  volume = {46},
  number = {3},
  doi = {10.1002/micr.70201}
}
Kostenlos starten →